Search terms
Results 1 - 3 of 3 - ordered by :

Nearly a quarter of patients with chronic ischaemic cardiovascular disease are dead or hospitalised within six months, reports a European Society of Cardiology (ESC) study published today in the ...

Date : 17/01/2018

Heart failure patients treated with the heart rate slowing agent ivabradine have a significantly reduced risk of being readmitted to hospital during the high-risk ‘vulnerable period’ just ...

Date : 21/05/2016

An analysis of the China Stroke Primary Prevention Trial presented at the 28th Great Wall International Congress of Cardiology (GW-ICC) and published in Neurology has identified a biomarker that can ...

Date : 26/10/2017